Rankings
▼
Calendar
BDSX FY 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
FY 2020 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$46M
+85.6% YoY
Gross Profit
$24M
51.7% margin
Operating Income
-$23M
-50.3% margin
Net Income
-$31M
-68.8% margin
EPS (Diluted)
$-6.48
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$24M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$121M
Total Liabilities
$80M
Stockholders' Equity
$41M
Cash & Equivalents
$62M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$25M
+85.6%
Gross Profit
$24M
$18M
+27.5%
Operating Income
-$23M
-$27M
+14.2%
Net Income
-$31M
-$31M
-2.0%
← Q4 2019
All Quarters
Q1 2020 →